Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

AMERISAFE (AMSF) Financials

AMERISAFE logo
$45.94 -0.42 (-0.91%)
Closing price 08/28/2025 04:00 PM Eastern
Extended Trading
$46.02 +0.08 (+0.16%)
As of 08/28/2025 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for AMERISAFE

Annual Income Statements for AMERISAFE

This table shows AMERISAFE's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 54 70 78 46 72 93 87 66 56 62 55
Consolidated Net Income / (Loss)		 54 70 78 46 72 93 87 66 56 62 55
Net Income / (Loss) Continuing Operations		 54 70 78 46 72 93 87 66 56 62 55
Total Pre-Tax Income 		74 101 113 82 88 116 107 79 68 77 69
Total Revenue		 404 401 397 375 378 370 339 316 295 307 309
Net Interest Income / (Expense)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Income		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Non-Interest Income		 404 401 397 375 378 370 339 316 295 307 309
Other Service Charges		 0.36 0.32 0.35 0.42 0.60 0.32 0.35 0.50 0.47 0.58 0.26
Net Realized & Unrealized Capital Gains on Investments		 28 25 28 29 27 37 35 39 23 39 38
Premiums Earned		 376 376 369 346 350 333 304 276 272 267 271
Total Non-Interest Expense		 330 300 284 293 290 255 233 236 227 229 240
Salaries and Employee Benefits		 52 52 51 50 52 52 51 47 48 51 55
Property & Liability Insurance Claims		 245 216 203 214 209 181 157 165 155 148 157
Insurance Policy Acquisition Costs		 33 32 29 28 29 22 24 25 24 30 28
Other Operating Expenses		 - - - - - - -0.03 -0.08 0.04 -0.06 -0.07
Income Tax Expense		 20 31 35 36 16 23 20 14 12 15 14
Basic Earnings per Share		 $2.88 $3.72 $4.08 $2.41 $3.73 $4.82 $4.49 $3.40 $2.89 $3.24 $2.91
Weighted Average Basic Shares Outstanding		 18.65M 18.94M 19.11M 19.17M 19.21M 19.25M 19.29M 19.33M 19.23M 19.15M 19.07M
Diluted Earnings per Share		 $2.84 $3.69 $4.05 $2.40 $3.71 $4.80 $4.47 $3.39 $2.88 $3.23 $2.89
Weighted Average Diluted Shares Outstanding		 18.93M 19.12M 19.20M 19.25M 19.29M 19.33M 19.36M 19.41M 19.32M 19.23M 19.16M
Weighted Average Basic & Diluted Shares Outstanding		 18.60M 18.90M 19.10M 19.20M 19.20M 19.20M 19.33M 19.36M 19.16M 19.14M 19.05M
Cash Dividends to Common per Share		 $0.48 $0.60 $0.72 $0.80 $0.88 $1.00 $1.08 $1.16 $1.24 $1.36 $1.48

Quarterly Income Statements for AMERISAFE

This table shows AMERISAFE's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders		 21 17 16 9.96 19 17 11 14 13 8.95 14
Consolidated Net Income / (Loss)		 21 17 16 9.96 19 17 11 14 13 8.95 14
Net Income / (Loss) Continuing Operations		 21 17 16 9.96 19 17 11 14 13 8.95 14
Total Pre-Tax Income 		26 22 20 12 24 21 14 18 17 11 17
Total Revenue		 80 78 76 73 80 80 76 79 74 73 81
Net Interest Income / (Expense)		 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Total Interest Income		 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Total Interest Expense		 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Total Non-Interest Income		 80 78 76 73 80 80 76 79 74 73 81
Other Service Charges		 0.12 0.20 0.21 0.08 0.09 0.12 -0.08 0.13 0.08 0.21 0.07
Net Realized & Unrealized Capital Gains on Investments		 14 9.06 9.85 5.93 14 12 7.27 12 7.44 3.50 12
Premiums Earned		 66 69 66 67 66 68 69 67 67 69 69
Total Non-Interest Expense		 54 57 56 60 56 60 62 61 57 61 64
Salaries and Employee Benefits		 12 12 13 13 14 13 13 13 15 14 14
Property & Liability Insurance Claims		 37 40 36 38 34 41 42 40 35 41 42
Insurance Policy Acquisition Costs		 4.94 5.16 7.43 9.49 8.39 5.31 7.27 7.87 7.08 6.26 8.05
Other Operating Expenses		 -0.02 -0.02 -0.02 -0.02 -0.01 -0.02 -0.02 -0.01 -0.02 -0.02 -0.01
Income Tax Expense		 4.87 4.20 3.94 2.37 4.77 3.82 2.75 3.47 3.58 2.27 3.50
Basic Earnings per Share		 $1.08 $0.91 $0.82 $0.52 $0.99 $0.89 $0.58 $0.75 $0.69 $0.47 $0.73
Weighted Average Basic Shares Outstanding		 19.23M 19.13M 19.14M 19.16M 19.15M 19.12M 19.08M 19.04M 19.07M 19.04M 19.04M
Diluted Earnings per Share		 $1.08 $0.90 $0.81 $0.52 $1.00 $0.88 $0.57 $0.75 $0.69 $0.47 $0.73
Weighted Average Diluted Shares Outstanding		 19.32M 19.24M 19.20M 19.22M 19.23M 19.21M 19.15M 19.11M 19.16M 19.15M 19.12M
Weighted Average Basic & Diluted Shares Outstanding		 19.16M 19.15M 19.18M 19.18M 19.14M 19.14M 19.07M 19.05M 19.05M 19.05M 18.99M
Cash Dividends to Common per Share		 $0.31 $0.34 $0.34 $0.34 $0.34 $0.37 $0.37 $0.37 $0.37 $0.39 $0.39

Annual Cash Flow Statements for AMERISAFE

This table details how cash moves in and out of AMERISAFE's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 -32 -21 -11 -3.38 -15 3.47 18 8.97 -9.25 -23 5.36
Net Cash From Operating Activities		 141 93 114 131 98 79 63 38 28 30 24
Net Cash From Continuing Operating Activities		 141 93 114 131 98 79 63 38 28 30 24
Net Income / (Loss) Continuing Operations		 54 70 78 46 72 93 87 66 56 62 55
Consolidated Net Income / (Loss)		 54 70 78 46 72 93 87 66 56 62 55
Depreciation Expense		 1.30 1.35 1.18 0.98 1.00 0.94 1.01 1.02 1.31 1.43 1.09
Amortization Expense		 15 16 16 14 11 8.66 8.18 8.87 6.73 3.03 1.45
Non-Cash Adjustments to Reconcile Net Income		 -0.59 5.83 -0.14 15 -2.29 -1.45 -0.35 -10 6.00 -5.62 -4.38
Changes in Operating Assets and Liabilities, net		 71 -1.20 19 54 17 -22 -32 -27 -41 -31 -29
Net Cash From Investing Activities		 -141 -50 -50 -52 -29 12 43 71 75 44 72
Net Cash From Continuing Investing Activities		 -141 -50 -50 -52 -29 12 43 71 75 44 72
Purchase of Property, Leasehold Improvements and Equipment		 -0.99 -0.95 -1.64 -0.48 -1.13 -1.02 -0.92 -1.30 -2.09 -0.55 -0.84
Purchase of Investment Securities		 -453 -326 -355 -402 -368 -346 -321 -271 -215 -134 -111
Sale and/or Maturity of Investments		 313 277 306 351 340 359 365 343 293 178 184
Net Cash From Financing Activities		 -32 -65 -74 -83 -84 -87 -89 -100 -113 -97 -91
Net Cash From Continuing Financing Activities		 -32 -65 -74 -83 -84 -87 -89 -100 -113 -97 -91
Repayment of Debt		 - - - 0.00 - - - -0.04 -0.06 -0.09 -0.09
Repurchase of Common Equity		 - - - - - - 0.00 0.00 -12 -2.17 -5.12
Payment of Dividends		 -37 -69 -76 -83 -84 -87 -89 -100 -100 -93 -85
Other Financing Activities, Net		 5.52 4.05 1.83 0.00 0.07 -0.03 -0.05 0.00 0.00 -0.94 -0.55
Cash Income Taxes Paid		 20 24 32 28 11 21 21 18 7.79 14 12

Quarterly Cash Flow Statements for AMERISAFE

This table details how cash moves in and out of AMERISAFE's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Change in Cash & Equivalents		 -29 -20 -7.29 25 -21 -5.31 -2.76 33 -20 0.71 3.71
Net Cash From Operating Activities		 -7.87 13 7.28 5.13 3.97 7.51 -2.59 8.45 11 -1.79 -8.44
Net Cash From Continuing Operating Activities		 -7.86 13 7.31 5.15 3.97 7.51 -2.56 8.46 11 -1.79 -8.42
Net Income / (Loss) Continuing Operations		 21 17 16 9.96 19 17 11 14 13 8.95 14
Consolidated Net Income / (Loss)		 21 17 16 9.96 19 17 11 14 13 8.95 14
Depreciation Expense		 0.36 0.35 0.35 0.37 0.36 0.33 0.23 0.28 0.26 0.21 0.20
Amortization Expense		 1.35 1.09 0.78 0.51 0.65 0.52 0.33 0.23 0.37 0.26 0.19
Non-Cash Adjustments to Reconcile Net Income		 -3.15 -1.45 -2.76 2.60 -4.01 -4.25 0.73 -2.82 1.96 4.12 -5.07
Changes in Operating Assets and Liabilities, net		 -27 -3.87 -6.69 -8.29 -12 -6.01 -15 -3.55 -4.93 -15 -18
Net Cash From Investing Activities		 61 -27 -7.15 27 51 -5.72 11 33 34 9.95 23
Net Cash From Continuing Investing Activities		 61 -27 -7.15 27 51 -5.72 11 33 34 9.95 23
Purchase of Property, Leasehold Improvements and Equipment		 -0.22 -0.03 -0.01 -0.49 -0.03 -0.75 -0.06 -0.02 -0.01 -0.00 -1.08
Purchase of Investment Securities		 -22 -51 -43 -29 -10 -42 -17 -27 -24 -10 -9.68
Sale and/or Maturity of Investments		 83 24 36 57 62 37 29 60 58 20 34
Net Cash From Financing Activities		 -83 -6.53 -7.42 -6.76 -76 -7.10 -12 -8.23 -64 -7.45 -11
Net Cash From Continuing Financing Activities		 -83 -6.53 -7.42 -6.76 -76 -7.10 -12 -8.23 -64 -7.45 -11
Payment of Dividends		 -82 -6.51 -6.62 -6.57 -74 -7.08 -7.10 -7.09 -64 -7.42 -7.49
Other Financing Activities, Net		 - -0.02 -0.76 -0.17 - -0.02 -0.41 -0.11 -0.01 -0.02 -0.65

Annual Balance Sheets for AMERISAFE

This table presents AMERISAFE's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 1,457 1,502 1,519 1,518 1,516 1,493 1,471 1,403 1,269 1,229 1,158
Cash and Due from Banks		 91 69 59 56 40 44 62 71 61 39 44
Trading Account Securities		 971 1,025 1,042 1,105 1,125 526 504 463 889 374 789
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accrued Investment Income		 12 12 11 11 10 9.73 9.27 8.08 8.43 8.27 7.33
Premises and Equipment, Net		 7.24 6.18 6.64 6.13 6.26 6.33 6.18 6.46 7.23 6.35 5.89
Unearned Premiums Asset		 179 185 183 174 162 158 157 135 122 133 143
Deferred Acquisition Cost		 20 20 19 20 20 19 18 17 17 18 19
Other Assets		 178 184 198 147 151 730 715 702 164 651 150
Total Liabilities & Shareholders' Equity		 1,457 1,502 1,519 1,518 1,516 1,493 1,471 1,403 1,269 1,229 1,158
Total Liabilities		 1,010 1,048 1,063 1,093 1,106 1,063 1,032 1,003 952 937 900
Claims and Claim Expense		 688 718 743 772 798 773 761 745 696 674 651
Unearned Premiums Liability		 169 168 162 157 149 141 129 121 115 117 122
Participating Policy Holder Equity		 49 48 49 48 47 45 42 39 36 35 34
Other Long-Term Liabilities		 105 114 109 115 112 104 101 98 105 112 93
Total Equity & Noncontrolling Interests		 447 454 456 425 410 430 439 399 317 292 257
Total Preferred & Common Equity		 447 454 456 425 410 430 439 399 317 292 257
Total Common Equity		 447 454 456 425 410 430 439 399 317 292 257
Common Stock		 199 205 209 210 212 213 216 218 221 222 224
Retained Earnings		 267 269 270 234 221 227 225 190 146 114 84
Treasury Stock		 -22 -22 -22 -22 -22 -22 -22 -22 -35 -37 -42
Accumulated Other Comprehensive Income / (Loss)		 2.81 2.59 -0.49 3.61 -0.83 12 21 14 -14 -7.19 -8.88

Quarterly Balance Sheets for AMERISAFE

This table presents AMERISAFE's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2022 Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025
Period end date 6/30/2022 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025
Total Assets		 1,382 1,359 1,288 1,299 1,297 1,243 1,234 1,255 1,157 1,155
Cash and Due from Banks		 85 91 41 34 59 33 31 64 45 48
Trading Account Securities		 425 420 920 929 889 101 389 399 67 374
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accrued Investment Income		 8.23 8.77 8.64 8.39 8.55 8.25 8.18 8.19 7.75 7.46
Premises and Equipment, Net		 6.89 7.38 6.91 6.56 6.68 6.77 6.38 6.13 5.68 6.56
Unearned Premiums Asset		 143 137 137 142 144 144 151 153 157 166
Deferred Acquisition Cost		 18 18 19 19 19 19 20 20 20 21
Other Assets		 695 677 156 160 170 931 629 604 854 531
Total Liabilities & Shareholders' Equity		 1,382 1,359 1,288 1,299 1,297 1,243 1,234 1,255 1,157 1,155
Total Liabilities		 997 986 955 958 961 942 933 940 896 890
Claims and Claim Expense		 725 716 687 685 684 668 664 663 640 624
Unearned Premiums Liability		 130 128 124 126 126 124 128 132 133 139
Participating Policy Holder Equity		 38 37 35 35 34 34 34 34 33 34
Other Long-Term Liabilities		 103 105 109 113 116 115 106 111 90 93
Total Equity & Noncontrolling Interests		 385 373 333 341 336 301 301 314 261 266
Total Preferred & Common Equity		 385 373 333 341 336 301 301 314 261 266
Total Common Equity		 385 373 333 341 336 301 301 314 261 266
Common Stock		 220 220 221 222 222 223 224 224 225 226
Retained Earnings		 202 207 156 165 169 124 128 135 86 92
Treasury Stock		 -28 -35 -35 -35 -35 -37 -41 -42 -42 -45
Accumulated Other Comprehensive Income / (Loss)		 -8.87 -20 -9.48 -12 -20 -8.74 -9.56 -2.68 -7.27 -7.56

Annual Metrics And Ratios for AMERISAFE

This table displays calculated financial ratios and metrics derived from AMERISAFE's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 13.38% -0.76% -1.07% -5.41% 0.68% -1.95% -8.34% -6.94% -6.71% 4.11% 0.71%
EBITDA Growth		 22.25% 31.51% 9.69% -25.34% 2.19% 25.92% -7.20% -23.06% -15.27% 8.11% -12.51%
EBIT Growth		 24.57% 36.91% 11.74% -27.11% 6.49% 31.90% -7.44% -25.69% -14.86% 14.39% -10.75%
NOPAT Growth		 22.98% 31.30% 10.51% -40.63% 54.94% 29.40% -6.57% -24.07% -15.44% 11.70% -10.74%
Net Income Growth		 22.98% 31.30% 10.51% -40.63% 54.94% 29.40% -6.57% -24.07% -15.44% 11.70% -10.74%
EPS Growth		 22.41% 29.93% 9.76% -40.74% 54.58% 29.38% -6.88% -24.16% -15.04% 12.15% -10.53%
Operating Cash Flow Growth		 8.92% -33.99% 23.00% 14.53% -24.88% -19.79% -19.57% -40.09% -25.76% 5.85% -18.94%
Free Cash Flow Firm Growth		 192.26% 169.86% 19.30% 1.67% 13.43% -17.25% 7.98% 34.93% 30.64% -36.66% 3.97%
Invested Capital Growth		 7.23% 1.57% 0.48% -6.74% -3.68% 4.99% 2.00% -9.00% -20.51% -7.87% -12.01%
Revenue Q/Q Growth		 -3.52% 0.29% 0.24% 5.10% -1.85% -16.67% 8.76% -0.87% 3,278.44% 0.12% -1.93%
EBITDA Q/Q Growth		 -36.38% 18.55% 1.66% 51.03% -8.71% 59.80% 53.12% 892.39% 127.29% -2.86% -9.53%
EBIT Q/Q Growth		 -41.24% 22.26% 2.11% 69.32% -9.01% 68.71% 60.81% 471.53% 123.68% -2.15% -9.41%
NOPAT Q/Q Growth		 -1.07% 9.66% -4.89% -28.50% 33.95% 19.63% -5.98% -27.51% 44.93% -2.51% -9.75%
Net Income Q/Q Growth		 -1.07% 9.66% -4.89% -28.50% 33.95% 19.63% -5.98% -27.51% 44.93% -2.51% -9.75%
EPS Q/Q Growth		 -1.05% 9.50% -5.37% -28.36% 33.94% 19.40% -6.09% -27.41% 45.45% -2.42% -9.69%
Operating Cash Flow Q/Q Growth		 6.43% -7.71% 1.07% -2.14% -0.97% -12.42% -5.68% -9.47% -36.81% 65.76% 39.58%
Free Cash Flow Firm Q/Q Growth		 263.23% 186.31% 20.73% -3.14% -2.38% 6.62% -1.18% 13.82% -5.50% -13.64% 9.18%
Invested Capital Q/Q Growth		 -0.34% -7.46% -10.51% -14.05% -10.73% -8.22% -8.94% -16.83% -14.90% -12.93% -18.14%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 22.35% 29.61% 32.84% 25.92% 26.30% 33.78% 34.20% 28.28% 25.68% 26.67% 23.17%
EBIT Margin		 18.25% 25.18% 28.44% 21.92% 23.18% 31.19% 31.50% 25.15% 22.95% 25.22% 22.35%
Profit (Net Income) Margin		 13.28% 17.57% 19.63% 12.32% 18.96% 25.03% 25.51% 20.81% 18.87% 20.24% 17.94%
Tax Burden Percent		 72.77% 69.79% 69.02% 56.21% 81.79% 80.24% 81.00% 82.77% 82.20% 80.27% 80.28%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 27.23% 30.21% 30.98% 43.79% 18.21% 19.76% 19.00% 17.24% 17.80% 19.73% 19.72%
Return on Invested Capital (ROIC)		 12.43% 15.64% 17.11% 10.49% 17.15% 22.07% 19.93% 15.69% 15.51% 20.37% 20.17%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Cash Return on Invested Capital (CROIC)		 5.44% 14.08% 16.63% 17.46% 20.90% 17.20% 17.95% 25.11% 38.37% 28.56% 32.94%
Operating Return on Assets (OROA)		 5.29% 6.82% 7.47% 5.42% 5.77% 7.68% 7.22% 5.53% 5.06% 6.19% 5.79%
Return on Assets (ROA)		 3.85% 4.76% 5.16% 3.04% 4.72% 6.16% 5.84% 4.58% 4.16% 4.97% 4.64%
Return on Common Equity (ROCE)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 12.01% 15.52% 17.07% 10.87% 17.48% 21.55% 19.74% 16.47% 17.52% 21.24% 21.54%
Net Operating Profit after Tax (NOPAT)		 54 70 78 46 72 93 87 66 56 62 55
NOPAT Margin		 13.28% 17.57% 19.63% 12.32% 18.96% 25.03% 25.51% 20.81% 18.87% 20.24% 17.94%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 12.97% 12.96% 12.89% 13.44% 13.81% 14.08% 15.04% 14.95% 16.28% 16.56% 17.88%
Operating Expenses to Revenue		 81.75% 74.82% 71.56% 78.08% 76.82% 68.81% 68.50% 74.85% 77.05% 74.78% 77.65%
Earnings before Interest and Taxes (EBIT)		 74 101 113 82 88 116 107 79 68 77 69
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 90 119 130 97 99 125 116 89 76 82 72
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.88 1.13 1.48 1.68 1.73 2.05 1.89 2.12 2.62 2.83 3.82
Price to Tangible Book Value (P/TBV)		 0.88 1.13 1.48 1.68 1.73 2.05 1.89 2.12 2.62 2.83 3.82
Price to Revenue (P/Rev)		 0.97 1.29 1.71 1.91 1.87 2.38 2.45 2.68 2.83 2.69 3.18
Price to Earnings (P/E)		 7.34 7.31 8.69 15.48 9.88 9.52 9.59 12.90 14.98 13.31 17.71
Dividend Yield		 8.32% 12.79% 10.77% 11.03% 2.40% 9.84% 11.25% 11.78% 2.85% 3.16% 8.69%
Earnings Yield		 13.63% 13.68% 11.51% 6.46% 10.12% 10.50% 10.43% 7.75% 6.67% 7.51% 5.65%
Enterprise Value to Invested Capital (EV/IC)		 0.68 0.98 1.35 1.55 1.63 1.95 1.75 1.95 2.43 2.69 3.64
Enterprise Value to Revenue (EV/Rev)		 0.75 1.11 1.56 1.76 1.77 2.26 2.26 2.46 2.62 2.57 3.03
Enterprise Value to EBITDA (EV/EBITDA)		 3.35 3.75 4.74 6.79 6.72 6.70 6.62 8.70 10.20 9.63 13.10
Enterprise Value to EBIT (EV/EBIT)		 4.10 4.41 5.47 8.03 7.62 7.26 7.19 9.79 11.41 10.18 13.58
Enterprise Value to NOPAT (EV/NOPAT)		 5.64 6.33 7.93 14.28 9.32 9.05 8.87 11.82 13.88 12.69 16.92
Enterprise Value to Operating Cash Flow (EV/OCF)		 2.15 4.80 5.41 5.05 6.79 10.64 12.12 20.47 27.37 26.41 38.77
Enterprise Value to Free Cash Flow (EV/FCFF)		 12.87 7.03 8.16 8.58 7.65 11.61 9.85 7.39 5.61 9.05 10.36
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage Ratio		 3.23 3.28 3.32 3.45 3.63 3.58 3.41 3.43 3.73 4.10 4.34
Compound Leverage Factor		 3.23 3.28 3.32 3.45 3.63 3.58 3.41 3.43 3.73 4.10 4.34
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 24 63 76 77 87 72 78 105 137 87 91
Operating Cash Flow to CapEx		 14,224.87% 9,743.86% 6,972.65% 27,366.11% 8,727.18% 7,743.03% 6,883.60% 2,983.43% 1,349.64% 5,396.38% 2,879.76%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.29 0.27 0.26 0.25 0.25 0.25 0.23 0.22 0.22 0.25 0.26
Fixed Asset Turnover		 54.64 59.75 61.90 58.79 61.00 58.84 54.26 49.99 43.08 45.21 50.51
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 447 454 456 425 410 430 439 399 317 292 257
Invested Capital Turnover		 0.94 0.89 0.87 0.85 0.90 0.88 0.78 0.75 0.82 1.01 1.12
Increase / (Decrease) in Invested Capital		 30 7.01 2.17 -31 -16 20 8.60 -39 -82 -25 -35
Enterprise Value (EV)		 303 446 618 660 668 839 768 778 772 788 938
Market Capitalization		 394 515 677 716 708 883 830 848 833 827 982
Book Value per Share		 $23.75 $23.78 $23.72 $22.11 $21.26 $22.29 $22.70 $20.62 $16.57 $15.25 $13.51
Tangible Book Value per Share		 $23.75 $23.78 $23.72 $22.11 $21.26 $22.29 $22.70 $20.62 $16.57 $15.25 $13.51
Total Capital		 447 454 456 425 410 430 439 399 317 292 257
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -91 -69 -59 -56 -40 -44 -62 -71 -61 -39 -44
Capital Expenditures (CapEx)		 0.99 0.95 1.64 0.48 1.13 1.02 0.92 1.27 2.09 0.55 0.84
Net Nonoperating Expense (NNE)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Obligations (NNO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Depreciation and Amortization (D&A)		 17 18 17 15 12 9.60 9.19 9.89 8.04 4.45 2.54
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $2.88 $3.72 $4.08 $2.41 $3.73 $4.82 $4.49 $3.40 $2.89 $3.24 $2.91
Adjusted Weighted Average Basic Shares Outstanding		 18.65M 18.94M 19.11M 19.17M 19.21M 19.25M 19.29M 19.33M 19.23M 19.15M 19.07M
Adjusted Diluted Earnings per Share		 $2.84 $3.69 $4.05 $2.40 $3.71 $4.80 $4.47 $3.39 $2.88 $3.23 $2.89
Adjusted Weighted Average Diluted Shares Outstanding		 18.93M 19.12M 19.20M 19.25M 19.29M 19.33M 19.36M 19.41M 19.32M 19.23M 19.16M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $4.82 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 18.92M 19.13M 19.23M 19.25M 19.27M 19.30M 19.33M 19.36M 19.16M 19.14M 19.05M
Normalized Net Operating Profit after Tax (NOPAT)		 54 70 78 46 72 93 87 66 56 62 55
Normalized NOPAT Margin		 13.28% 17.57% 19.63% 12.32% 18.96% 25.03% 25.51% 20.81% 18.87% 20.24% 17.94%
Pre Tax Income Margin		 18.25% 25.18% 28.44% 21.92% 23.18% 31.19% 31.50% 25.15% 22.95% 25.22% 22.35%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 69.07% 97.30% 97.75% 178.77% 117.95% 93.88% 102.51% 151.97% 180.62% 150.23% 154.12%
Augmented Payout Ratio		 69.07% 97.30% 97.75% 178.77% 117.95% 93.88% 102.51% 151.97% 202.90% 153.73% 163.36%

Quarterly Metrics And Ratios for AMERISAFE

This table displays calculated financial ratios and metrics derived from AMERISAFE's official financial filings.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 135.57% 3.81% 11.20% 1.77% 0.45% 2.61% 0.23% 8.34% -7.60% -9.81% 6.93%
EBITDA Growth		 108.40% -3.40% 123.54% -13.59% -8.82% -6.02% -30.90% 38.54% -30.24% -45.83% 24.70%
EBIT Growth		 107.83% 0.53% 174.72% -8.36% -6.64% -3.67% -29.76% 44.34% -29.95% -45.91% 27.00%
NOPAT Growth		 486.78% 0.05% 154.84% -12.32% -7.69% -2.39% -29.65% 43.80% -31.21% -47.13% 26.94%
Net Income Growth		 486.78% 0.05% 154.84% -12.32% -7.69% -2.39% -29.65% 43.80% -31.21% -47.13% 26.94%
EPS Growth		 500.00% 1.12% 153.13% -11.86% -7.41% -2.22% -29.63% 44.23% -31.00% -46.59% 28.07%
Operating Cash Flow Growth		 -192.02% 89.18% -59.28% -53.67% 150.39% -44.26% -135.62% 64.63% 172.93% -123.87% -225.73%
Free Cash Flow Firm Growth		 138.58% 14.46% -32.91% -60.26% -56.99% -38.96% -15.79% -23.91% 9.38% 1.12% -2.36%
Invested Capital Growth		 -20.51% -15.79% -11.54% -9.96% -7.87% -9.54% -11.62% -6.40% -12.01% -13.38% -11.77%
Revenue Q/Q Growth		 11.74% -1.66% -3.54% -3.99% 10.29% 0.47% -5.79% 3.78% -5.93% -1.93% 11.70%
EBITDA Q/Q Growth		 78.99% -16.02% -9.91% -36.19% 88.88% -13.45% -33.76% 27.95% -4.90% -32.79% 52.49%
EBIT Q/Q Growth		 90.69% -16.04% -9.13% -37.00% 94.26% -13.37% -33.75% 29.46% -5.73% -33.10% 55.56%
NOPAT Q/Q Growth		 82.89% -16.55% -9.87% -36.26% 92.56% -11.76% -35.05% 30.30% -7.89% -32.17% 55.94%
Net Income Q/Q Growth		 82.89% -16.55% -9.87% -36.26% 92.56% -11.76% -35.05% 30.30% -7.89% -32.17% 55.94%
EPS Q/Q Growth		 83.05% -16.67% -10.00% -35.80% 92.31% -12.00% -35.23% 31.58% -8.00% -31.88% 55.32%
Operating Cash Flow Q/Q Growth		 -171.06% 271.06% -45.96% -29.48% -22.70% 89.21% -134.53% 425.96% 28.15% -116.55% -371.15%
Free Cash Flow Firm Q/Q Growth		 -13.36% -22.32% -24.71% -21.57% -6.23% 10.24% 3.87% -29.13% 34.79% 1.92% 0.30%
Invested Capital Q/Q Growth		 -14.90% 4.86% 2.32% -1.38% -12.93% 2.96% -0.03% 4.45% -18.14% 1.35% 1.82%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 34.30% 29.29% 27.36% 18.18% 31.14% 26.83% 18.86% 23.25% 23.51% 16.11% 21.99%
EBIT Margin		 32.16% 27.45% 25.86% 16.97% 29.89% 25.77% 18.12% 22.61% 22.66% 15.46% 21.53%
Profit (Net Income) Margin		 26.05% 22.11% 20.65% 13.71% 23.94% 21.03% 14.50% 18.20% 17.82% 12.33% 17.21%
Tax Burden Percent		 81.01% 80.52% 79.86% 80.81% 80.10% 81.59% 79.98% 80.50% 78.66% 79.75% 79.95%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 18.99% 19.48% 20.14% 19.19% 19.90% 18.41% 20.02% 19.50% 21.34% 20.25% 20.05%
Return on Invested Capital (ROIC)		 21.42% 18.07% 17.38% 11.86% 24.09% 20.49% 13.97% 17.64% 20.04% 13.21% 18.61%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Cash Return on Invested Capital (CROIC)		 38.37% 32.42% 30.19% 28.45% 28.56% 29.48% 30.13% 25.51% 32.94% 31.23% 30.30%
Operating Return on Assets (OROA)		 7.09% 6.10% 5.89% 3.92% 7.34% 6.29% 4.42% 5.59% 5.87% 3.88% 5.52%
Return on Assets (ROA)		 5.75% 4.91% 4.70% 3.16% 5.88% 5.13% 3.54% 4.50% 4.62% 3.09% 4.42%
Return on Common Equity (ROCE)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 16.71% 19.12% 18.97% 0.00% 20.49% 18.96% 19.54% 0.00% 18.20% 18.99%
Net Operating Profit after Tax (NOPAT)		 21 17 16 9.96 19 17 11 14 13 8.95 14
NOPAT Margin		 26.05% 22.11% 20.65% 13.71% 23.94% 21.03% 14.50% 18.20% 17.82% 12.33% 17.21%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 15.65% 15.08% 16.58% 17.73% 16.92% 16.63% 17.35% 17.01% 20.70% 19.75% 16.89%
Operating Expenses to Revenue		 67.84% 72.55% 74.14% 83.03% 70.11% 74.23% 81.88% 77.39% 77.34% 84.54% 78.47%
Earnings before Interest and Taxes (EBIT)		 26 22 20 12 24 21 14 18 17 11 17
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 27 23 21 13 25 22 14 18 17 12 18
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.62 2.54 2.72 2.59 2.83 3.17 2.79 2.93 3.82 3.84 3.14
Price to Tangible Book Value (P/TBV)		 2.62 2.54 2.72 2.59 2.83 3.17 2.79 2.93 3.82 3.84 3.14
Price to Revenue (P/Rev)		 2.83 2.84 3.03 2.84 2.69 3.09 2.72 2.92 3.18 3.32 2.72
Price to Earnings (P/E)		 14.98 15.18 14.21 13.64 13.31 15.46 14.72 15.00 17.71 21.09 16.52
Dividend Yield		 2.85% 2.88% 2.69% 2.94% 3.16% 2.79% 3.24% 3.00% 8.69% 8.56% 10.34%
Earnings Yield		 6.67% 6.59% 7.04% 7.33% 7.51% 6.47% 6.79% 6.67% 5.65% 4.74% 6.05%
Enterprise Value to Invested Capital (EV/IC)		 2.43 2.41 2.62 2.41 2.69 3.06 2.69 2.73 3.64 3.67 2.95
Enterprise Value to Revenue (EV/Rev)		 2.62 2.70 2.92 2.64 2.57 2.98 2.62 2.72 3.03 3.18 2.56
Enterprise Value to EBITDA (EV/EBITDA)		 10.20 10.72 10.32 9.61 9.63 11.44 10.93 10.84 13.10 15.50 12.03
Enterprise Value to EBIT (EV/EBIT)		 11.41 11.85 11.11 10.24 10.18 12.02 11.44 11.25 13.58 16.06 12.41
Enterprise Value to NOPAT (EV/NOPAT)		 13.88 14.44 13.69 12.71 12.69 14.92 14.18 13.97 16.92 20.15 15.56
Enterprise Value to Operating Cash Flow (EV/OCF)		 27.37 23.24 37.21 44.98 26.41 38.55 57.75 49.50 38.77 64.22 86.78
Enterprise Value to Free Cash Flow (EV/FCFF)		 5.61 6.80 8.14 8.03 9.05 9.85 8.37 10.34 10.36 10.90 9.14
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage Ratio		 3.73 3.68 3.69 3.75 4.10 3.99 3.95 3.92 4.34 4.27 4.22
Compound Leverage Factor		 3.73 3.68 3.69 3.75 4.10 3.99 3.95 3.92 4.34 4.27 4.22
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 103 80 60 47 44 49 51 36 48 49 49
Operating Cash Flow to CapEx		 -3,627.65% 42,081.25% 145,540.00% 1,047.35% 15,257.69% 1,006.17% -4,628.57% 35,204.17% 77,335.71% -89,600.00% -780.31%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.22 0.22 0.23 0.23 0.25 0.24 0.24 0.25 0.26 0.25 0.26
Fixed Asset Turnover		 43.08 44.65 45.39 43.60 45.21 45.18 47.75 49.20 50.51 48.41 47.33
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 317 333 341 336 292 301 301 314 257 261 266
Invested Capital Turnover		 0.82 0.82 0.84 0.86 1.01 0.97 0.96 0.97 1.12 1.07 1.08
Increase / (Decrease) in Invested Capital		 -82 -62 -44 -37 -25 -32 -40 -22 -35 -40 -35
Enterprise Value (EV)		 772 803 891 810 788 921 809 858 938 956 785
Market Capitalization		 833 844 925 869 827 954 840 922 982 1,001 833
Book Value per Share		 $16.57 $17.38 $17.78 $17.51 $15.25 $15.75 $15.73 $16.49 $13.51 $13.69 $13.94
Tangible Book Value per Share		 $16.57 $17.38 $17.78 $17.51 $15.25 $15.75 $15.73 $16.49 $13.51 $13.69 $13.94
Total Capital		 317 333 341 336 292 301 301 314 257 261 266
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -61 -41 -34 -59 -39 -33 -31 -64 -44 -45 -48
Capital Expenditures (CapEx)		 0.22 0.03 0.01 0.49 0.03 0.75 0.06 0.02 0.01 0.00 1.08
Net Nonoperating Expense (NNE)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Obligations (NNO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Depreciation and Amortization (D&A)		 1.71 1.44 1.13 0.88 1.00 0.85 0.56 0.51 0.63 0.48 0.38
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.08 $0.91 $0.82 $0.52 $0.99 $0.89 $0.58 $0.75 $0.69 $0.47 $0.73
Adjusted Weighted Average Basic Shares Outstanding		 19.23M 19.13M 19.14M 19.16M 19.15M 19.12M 19.08M 19.04M 19.07M 19.04M 19.04M
Adjusted Diluted Earnings per Share		 $1.08 $0.90 $0.81 $0.52 $1.00 $0.88 $0.57 $0.75 $0.69 $0.47 $0.73
Adjusted Weighted Average Diluted Shares Outstanding		 19.32M 19.24M 19.20M 19.22M 19.23M 19.21M 19.15M 19.11M 19.16M 19.15M 19.12M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 19.16M 19.15M 19.18M 19.18M 19.14M 19.14M 19.07M 19.05M 19.05M 19.05M 18.99M
Normalized Net Operating Profit after Tax (NOPAT)		 21 17 16 9.96 19 17 11 14 13 8.95 14
Normalized NOPAT Margin		 26.05% 22.11% 20.65% 13.71% 23.94% 21.03% 14.50% 18.20% 17.82% 12.33% 17.21%
Pre Tax Income Margin		 32.16% 27.45% 25.86% 16.97% 29.89% 25.77% 18.12% 22.61% 22.66% 15.46% 21.53%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 180.62% 181.53% 155.95% 160.37% 150.23% 152.17% 165.38% 154.48% 154.12% 180.75% 170.90%
Augmented Payout Ratio		 202.90% 181.53% 166.22% 160.60% 153.73% 152.17% 176.39% 166.35% 163.36% 180.75% 178.44%

Key Financial Trends

AMERISAFE Inc. (NASDAQ: AMSF) has shown overall solid financial performance over the last four years, with steady growth in earnings and equity, though some fluctuations highlight areas to watch.

Positive Highlights:

  • Net income has generally increased, from $6.13 million in Q2 2022 to $13.96 million in Q2 2025, reflecting improved profitability.
  • Premiums earned grew steadily, reaching nearly $69.4 million in Q2 2025, indicating growth in the company’s core insurance business.
  • Total common equity increased from approximately $301 million in Q1 2024 to about $266 million in Q2 2025, showing strong retained earnings and shareholder equity base.
  • Cash and cash equivalents rose from $30.6 million in Q2 2024 to $48.5 million in Q2 2025, improving liquidity.
  • AMSF consistently generates significant net cash from investing activities, driven by investment securities sales outpacing purchases, supporting strong cash flow positions each quarter.
  • Dividends have been consistently paid at around $0.31 to $0.39 per share, reflecting a stable cash return policy to shareholders.
  • Diluted earnings per share growth from $0.32 in Q2 2022 to $0.73 in Q2 2025 demonstrates healthy earnings expansion on a per-share basis.
  • Non-interest income, mainly from realized and unrealized capital gains, has increased significantly, reaching over $81 million in Q2 2025, enhancing revenue diversity beyond insurance underwriting.

Neutral Observations:

  • The company carries substantial liabilities related to claims and claim expenses, above $620 million as of Q2 2025, which is typical for insurance firms but requires ongoing management.
  • Basic and diluted shares outstanding have remained fairly stable over time, around 19 to 20 million shares, implying limited dilution from share issuance.

Potential Concerns:

  • Net cash from continuing operating activities has seen volatility and negative values in recent quarters (e.g., -$8.4 million in Q2 2025), driven by changes in operating assets and liabilities, which could indicate working capital management challenges.
  • The total liabilities increased through the years up to nearly $890 million in Q2 2025; while this aligns with growing business, it increases the company's financial obligations substantially.
  • Other long-term liabilities increased to $92.7 million in Q2 2025 from lower amounts previously, which might affect long-term financial flexibility.

Summary: AMSF has demonstrated strong and growing profitability with consistent revenue growth primarily driven by insurance premiums and capital gains. Its equity base and liquidity have improved, supporting ongoing operations and dividends. However, fluctuations in operating cash flow and increasing liabilities highlight areas investors should monitor closely. The company’s ability to manage its working capital and liability exposure will be key to maintaining financial health moving forward.

08/29/25 07:38 AM ETAI Generated. May Contain Errors.

Financials Breakdown Chart

Frequently Asked Questions About AMERISAFE's Financials

When does AMERISAFE's fiscal year end?

According to the most recent income statement we have on file, AMERISAFE's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has AMERISAFE's net income changed over the last 10 years?

AMERISAFE's net income were at $55.44 million at the end of 2024, a 10.7% decrease from 2023, and a 3.3% increase since 2014. See AMERISAFE's forecast for analyst expectations on what’s next for the company.

How has AMERISAFE's revenue changed over the last 10 years?

Over the last 10 years, AMERISAFE's total revenue changed from $404.02 million in 2014 to $309.04 million in 2024, a change of -23.5%.

How much debt does AMERISAFE have?

AMERISAFE's total liabilities were at $900.45 million at the end of 2024, a 3.9% decrease from 2023, and a 10.9% decrease since 2014.

How much cash does AMERISAFE have?

In the past 10 years, AMERISAFE's cash and equivalents has ranged from $38.68 million in 2023 to $90.96 million in 2014, and is currently $44.05 million as of their latest financial filing in 2024.

How has AMERISAFE's book value per share changed over the last 10 years?

Over the last 10 years, AMERISAFE's book value per share changed from 23.75 in 2014 to 13.51 in 2024, a change of -43.1%.


Related Companies

This page (NASDAQ:AMSF) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...
Brownstone Research | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
Out of 18,347 Cryptocurrencies... This is the ONLY One
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...
Crypto 101 Media | Sponsoredtc pixel